Search

Photocatalytic degradation is one of the most promising emerging technologies for environmental pollution control. However, the preparation of efficient, low-cost photocatalysts still faces many challenges. TiO2 is a widely available and inexpensive photocatalyst material, but improving its catalytic degradation performance has posed a significant challenge due to its shortcomings, such as the easy recombination of its photogenerated electron–hole pairs and its difficulty in absorbing visible light. The construction of homogeneous heterojunctions is an effective means to enhance the photocatalytic performances of photocatalysts. In this study, a TiO2(B)/TiO2(A) homogeneous heterojunction composite photocatalyst (with B and A denoting bronze and anatase phases, respectively) was successfully constructed in situ. Although the construction of homogeneous heterojunctions did not improve the light absorption performance of the material, its photocatalytic degradation performance was substantially enhanced. This was due to the suppression of the recombination of photogenerated electron–hole pairs and the enhancement of the carrier mobility. The photocatalytic ability of the TiO2(B)/TiO2(A) homogeneous heterojunction composite photocatalyst was up to three times higher than that of raw TiO2 (pure anatase TiO2). [ABSTRACT FROM AUTHOR]

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease, along with the prevalence of obesity and metabolic syndrome. Non-alcoholic fatty liver will progress to non-alcoholic steatohepatitis (NASH), NASH-related liver fibrosis and liver cirrhosis, and even hepatocellular carcinoma. Accurate assessment and early intervention are conducive to clinical burden reduction and disease control. Although being the "golden standard" for diagnosing NAFLD, the clinical application of liver biopsy is limited due to well-known limitations and significant complications. Serological testing, as a noninvasive method, has been well-recognized among researchers and clinicians. The understanding of the pros and cons and the application ranges of various methods and indexes is helpful for clinical applications, including providing more diagnosis approaches, improving diagnosis power, relieving pain of patients, and saving medical resources. This article reviews the advances in serological noninvasive diagnostic methods for NAFLD. [ABSTRACT FROM AUTHOR]

Pulsed Eddy current (PEC) is an emerging nondestructive evaluation (NDT) technique excited with a broadband pulse that consists of rich frequency information. This technique generally uses the response peak value and peak arrival time to detect and quantify defects, which is not sufficient to achieve enough information associated with flaw quantification. This article introduces the application of empirical mode decomposition and Hilbert transform in extracting a new frequency domain feature from PEC responses. Time and frequency features are combined to enhance the accuracy of defect classification. The validation and robustness of the new feature and the improved classification by experimental studies are presented. [ABSTRACT FROM PUBLISHER]

Recognizing the appearance parameters of defects is the main object in the signal processing of offshore oil pipeline inspection. Based on the feature extraction of magnetic flux leakage (MFL) inspection data, a modified back-propagation (BP) neural network system were presented to recognize pipeline defect and corrosion. The process of teaching and testing of BP neural networks to characterize the defect signals was analyzed. The adjusting method of network output weight and rate of learning based on Levenberg-Marquardt algorithm was also discussed. In order to obtain the perfect structure parameters of network and research each parameter's effect on the performance of network, a large number of simulation tests were conducted. The MFL data processing experiment proves that the defect recognition neural network system has high convergence speed and good ability of approaching defect features. [ABSTRACT FROM AUTHOR]

Acute myeloid leukemia (AML) is a group of hematological malignancies with high heterogeneity. There is an increasing need to improve the risk stratification of AML patients, including those with normal cytogenetics, using molecular biomarkers. Here, we report a metabolomics study that identified a distinct glucose metabolism signature with 400 AML patients and 446 healthy controls. The glucose metabolism signature comprises a panel of 6 serum metabolite markers, which demonstrated prognostic value in cytogenetically normal AML patients. We generated a prognosis risk score (PRS) with 6 metabolite markers for each patient using principal component analysis. A low PRS was able to predict patients with poor survival independently of well-established markers. We further compared the gene expression patterns of AML blast cells between low and high PRS groups, which correlated well to the metabolic pathways involving the 6 metabolite markers, with enhanced glycolysis and tricarboxylic [corrected] acid cycle at gene expression level in low PRS group. In vitro results demonstrated enhanced glycolysis contributed to decreased sensitivity to antileukemic agent arabinofuranosyl cytidine (Ara-C), whereas inhibition of glycolysis suppressed AML cell proliferation and potentiated cytotoxicity of Ara-C. Our study provides strong evidence for the use of serum metabolites and metabolic pathways as novel prognostic markers and potential therapeutic targets for AML., (© 2014 by The American Society of Hematology.)

Gastric cardia cancer (GCC), which occurs at the gastric-esophageal boundary, is one of the most malignant tumors. Despite its high mortality and morbidity, the molecular mechanism of initiation and progression of this disease is largely unknown. In this study, using proteomics and metabolomics approaches, we found that the level of several enzymes and their related metabolic intermediates involved in glucose metabolism were deregulated in GCC. Among these enzymes, two subunits controlling pyruvic acid efflux, lactate dehydrogenase A (LDHA) and pyruvate dehydrogenase B (PDHB), were further analyzed in vitro. Either down-regulation of LDH subunit LDHA or overexpression of PDH subunit PDHB could force pyruvic acid into the Krebs cycle rather than the glycolysis process in AGS gastric cancer cells, which inhibited cell growth and cell migration. Our results reflect an important glucose metabolic signature, especially the dysregulation of pyruvic acid efflux in the development of GCC. Forced transition from glycolysis to the Krebs cycle had an inhibitory effect on GCC progression, providing potential therapeutic targets for this disease.